About Oralucent
Oralucent is a private company based in Summit, New Jersey. It has reported $2,270,000 raised in three offerings on Form D since May 2019. Its chief executive is Hans Kaspersetz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Apr 10, 2026 | $520,000of $1.2M target | 5 | $104K | DebtRule 506(b) | Form D ↗ |
| Dec 24, 2020 | Jan 8, 2021 | $750,000fully sold | 11 | $68,182 | Debt, OptionsRule 506(b) | Form D ↗ |
| Apr 23, 2019 | May 8, 2019 | $1,000,000fully sold | 11 | $90,909 | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $2,270,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Oralucent's Form D filed Apr 10, 2026.
Earlier filings also listed Jacqueline Courtiol (executive officer and director, last listed Jan 2021).